Viennese approach to minimize the invasiveness of ventricular assist device implantation
Open Access
- 12 March 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 46 (6) , 991-996
Abstract
Avoiding full sternotomy and cardiopulmonary bypass (CPB) could significantly reduce the invasiveness of left ventricular assist device (LVAD) implantation. Therefore, we developed minimally invasive implant strategies for the Heartware® VAD (HVAD) and the Thoratec® HeartMate II (HMII) covering isolated LVAD implantation as well as concomitant valve procedures (aortic/tricuspid). We present the surgical techniques and the initial clinical experience. From February 2012 to March 2013, 27 patients (mean age 58 ± 8 years; male 85%; Ischemic Cardiomyopathy 63%; redo surgery 22%; Interagency Registry for Mechanically Assisted Circulatory Support Level I: 29%, II: 22%, III: 33%, IV–VII: 16%) underwent minimally invasive LVAD implantation at our department. Apical cannulation was performed via a left lateral minithoracotomy in HVAD patients (n = 20) or a left subcostal incision in HMII patients (n = 7). The outflow graft anastomosis was performed to the ascending aorta via a right minithoracotomy in the second intercostal space (n = 22) or the right subclavian artery (n = 2). If additional valve procedures (aortic/tricuspid) were necessary (n = 3), a hemisternotomy was performed to access the valve and perform the outflow graft anastomosis. Circulatory support for LVAD implantation was CPB (33%), extracorporeal membrane oxygenation (48%) or off-pump (19%). The minimally invasive approach was feasible in all patients with no need for conversions. Thirty-day and in-hospital mortality were 7.4 and 14.8%, respectively. In-hospital stay was 30.0 ± 22.5 days. One patient (4%) died during follow-up from pump thrombus formation. Three patients (11%) underwent surgical revision for bleeding. Minimally invasive LVAD implantation is feasible and safe. The very encouraging results obtained in this initial series justify a broad application of this technique.Keywords
This publication has 18 references indexed in Scilit:
- Minimally Invasive Thoratec Heartmate II Implantation in the Setting of Severe Thoracic Aortic CalcificationThe Annals of Thoracic Surgery, 2013
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: Upper hemisternotomy combined with anterolateral thoracotomyThe Journal of Thoracic and Cardiovascular Surgery, 2012
- HeartWare Left Ventricular Assist Device Implantation Through Bilateral Anterior ThoracotomyThe Annals of Thoracic Surgery, 2012
- Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trialThe Journal of Heart and Lung Transplantation, 2010
- Minimally-Invasive Valve SurgeryJACC, 2010
- The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incisionAmerican Heart Journal, 2010
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DeviceJACC, 2009
- One Thousand Minimally Invasive Valve OperationsAnnals of Surgery, 2004
- Role of Pericardial Constraint for Right Ventricular Function in HumansChest, 1995